This week we’re speaking with a woman who’s on a mission to make other women, “really f***ing rich.” And who doesn’t like the sound of that? Cindy Eckert, founder and CEO of Sprout Pharmaceuticals is leading this charge, while simultaneously supercharging our sex lives. Her company — which she sold for $1 billion and bought back for practically nothing — created Addyi, the first ever FDA-approved drug for low sexual desire in women.
We talk hormones, big pharma, negotiations and how to handle sexism. Her strategy: “Kill them with competence.” It’s a must-listen. In Mailbag, we dive into credit cards, student loans and other financial trade-offs. And, in Thrive, we discuss troubling research on the big little lies we tell when women outearn their husbands.
This podcast is proudly supported by Fidelity Investments. Join the Fidelity® Women Talk Money pop-up for access to virtual live events in March, with guests including Jean Chatzky. You'll also get weekly action steps for a healthier financial future. Get started at Fidelity.com/HerMoney. Brokerage Services LLC Member NYSE, SIPC.